Cargando...
PPAR Agonists for the Prevention and Treatment of Lung Cancer
Lung cancer is the most common and most fatal of all malignancies worldwide. Furthermore, with more than half of all lung cancer patients presenting with distant metastases at the time of initial diagnosis, the overall prognosis for the disease is poor. There is thus a desperate need for new prevent...
Gardado en:
| Publicado en: | PPAR Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5337885/ https://ncbi.nlm.nih.gov/pubmed/28316613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8252796 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|